210 Diagnostics is a startup biotechnology companythat is commercializing a new autoimmune andinfectious diseases antibody test. This testcan be run on-site at healthcare facilities, eliminatingthe need to outsource tests to external laboratories, andproduces a result in 3.5 minutes, or 210 seconds. Therevolutionary nature of our test will help hospitals savetime and money and help patients receive their testresults faster.We aim to improve diagnostics and disease monitoring systems in an inexpensive, fast, and accurate way to better serve patients and their families to make healthcare work for everyone. We will ethically source our materials and monitor our environmental impact. In doing so, we aim to be outwardly transparent in our actions, conduct our business in an ethical and socially responsible manner, and lead the charge to reinstall trust and support in the healthcare and scientific communities.